Steven A. Porcelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Steven A. Porcelli has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Gurdyal Singh Besra
Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham, UK
5 shared publications Jin S. Im
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
4 shared publicationsManjunatha M. Venkataswamy
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
4 shared publicationsPetr A. Illarionov
School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
4 shared publicationsAlberto Molano
Department of Microbiology and Immunology , Albert Einstein College of Medicine, Bronx, NY 10461, USA
3 shared publicationsMasahiko Sugita
Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA, and
3 shared publications
Latest Publications
- 1 April 2010
- Published by Elsevier in Seminars in Immunology
- Vol. 22 (2) , 68-78
Lipid and glycolipid antigens of CD1d-restricted natural killer T cells
- 1 April 2010
- Published by Elsevier in Seminars in Immunology
- Vol. 22 (2) , 68-78
Lipid and glycolipid antigens of CD1d-restricted natural killer T cells
- Open Access
- 5 August 2009
- Published by Wiley in Tissue Antigens
- Vol. 74 (3) , 189-204
Evasion and subversion of antigen presentation by Mycobacterium tuberculosis
Mycobacterium tuberculosis is one of the most successful of human pathogens and has acquired the ability to establish latent or progressive infection and persist even in the presence of a fully functioning immune system. The ability of M. tuberculosis to avoid immune‐mediated clearance is likely to reflect a highly evolved and coordinated program of immune evasion strategies, including some that interfere with antigen presentation to prevent or alter the quality of T‐cell responses. Here, we review an extensive array of published studies supporting the view that antigen presentation pathways are targeted at many points by pathogenic mycobacteria. These studies show the multiple potential mechanisms by which M. tuberculosis may actively inhibit, subvert or otherwise modulate antigen presentation by major histocompatibility complex class I, class II and CD1 molecules. Unraveling the mechanisms by which M. tuberculosis evades or modulates antigen presentation is of critical importance for the development of more effective new vaccines based on live attenuated mycobacterial strains.
- 5 August 2009
- Published by Wiley in Tissue Antigens
- Vol. 74 (3) , 189-204
Open AccessEvasion and subversion of antigen presentation by Mycobacterium tuberculosis
Mycobacterium tuberculosis is one of the most successful of human pathogens and has acquired the ability to establish latent or progressive infection and persist even in the presence of a fully functioning immune system. The ability of M. tuberculosis to avoid immune‐mediated clearance is likely to reflect a highly evolved and coordinated program of immune evasion strategies, including some that interfere with antigen presentation to prevent or alter the quality of T‐cell responses. Here, we review an extensive array of published studies supporting the view that antigen presentation pathways are targeted at many points by pathogenic mycobacteria. These studies show the multiple potential mechanisms by which M. tuberculosis may actively inhibit, subvert or otherwise modulate antigen presentation by major histocompatibility complex class I, class II and CD1 molecules. Unraveling the mechanisms by which M. tuberculosis evades or modulates antigen presentation is of critical importance for the development of more effective new vaccines based on live attenuated mycobacterial strains.
- Open Access
- 1 August 2009
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 183 (3) , 1644-1656
Incorporation of NKT Cell-Activating Glycolipids Enhances Immunogenicity and Vaccine Efficacy of Mycobacterium bovis Bacillus Calmette-Guérin
The attenuated strain of Mycobacterium bovis known as bacille Calmette-Guérin (BCG) has been widely used as a vaccine for prevention of disease by Mycobacterium tuberculosis, but with relatively little evidence of success. Recent studies suggest that the failure of BCG may be due to its retention of immune evasion mechanisms that delay or prevent the priming of robust protective cell-mediated immunity. In this study, we describe an approach to enhance the immunogenicity of BCG by incorporating glycolipid activators of CD1d-restricted NKT cells, a conserved T cell subset with the potential to augment many types of immune responses. A method was developed for stably incorporating two forms of the NKT cell activator α-galactosylceramide into live BCG organisms, and the impact of this on stimulation of T cell responses and protective antimycobacterial immunity was evaluated. We found that live BCG containing relatively small amounts of incorporated α-galactosylceramide retained the ability to robustly activate NKT cells. Compared with immunization with unmodified BCG, the glycolipid-modified BCG stimulated increased maturation of dendritic cells and markedly augmented the priming of Ag-specific CD8+ T cells responses. These effects were correlated with improved protective effects of vaccination in mice challenged with virulent M. tuberculosis. These results support the view that mycobacteria possess mechanisms to avoid stimulation of CD8+ T cell responses and that such responses contribute significantly to protective immunity against these pathogens. Our findings raise the possibility of a simple modification of BCG that could yield a more effective vaccine for control of tuberculosis.
- 1 August 2009
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 183 (3) , 1644-1656
Open AccessIncorporation of NKT Cell-Activating Glycolipids Enhances Immunogenicity and Vaccine Efficacy of Mycobacterium bovis Bacillus Calmette-Guérin
The attenuated strain of Mycobacterium bovis known as bacille Calmette-Guérin (BCG) has been widely used as a vaccine for prevention of disease by Mycobacterium tuberculosis, but with relatively little evidence of success. Recent studies suggest that the failure of BCG may be due to its retention of immune evasion mechanisms that delay or prevent the priming of robust protective cell-mediated immunity. In this study, we describe an approach to enhance the immunogenicity of BCG by incorporating glycolipid activators of CD1d-restricted NKT cells, a conserved T cell subset with the potential to augment many types of immune responses. A method was developed for stably incorporating two forms of the NKT cell activator α-galactosylceramide into live BCG organisms, and the impact of this on stimulation of T cell responses and protective antimycobacterial immunity was evaluated. We found that live BCG containing relatively small amounts of incorporated α-galactosylceramide retained the ability to robustly activate NKT cells. Compared with immunization with unmodified BCG, the glycolipid-modified BCG stimulated increased maturation of dendritic cells and markedly augmented the priming of Ag-specific CD8+ T cells responses. These effects were correlated with improved protective effects of vaccination in mice challenged with virulent M. tuberculosis. These results support the view that mycobacteria possess mechanisms to avoid stimulation of CD8+ T cell responses and that such responses contribute significantly to protective immunity against these pathogens. Our findings raise the possibility of a simple modification of BCG that could yield a more effective vaccine for control of tuberculosis.
- Open Access
Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation
- 6 August 2008
- Published by Springer Nature in Nature
- Vol. 454 (7205) , 702-703
Shrewd survival strategy
- 6 August 2008
- Published by Springer Nature in Nature
- Vol. 454 (7205) , 702-703
Shrewd survival strategy
- 1 April 2008
- Published by Elsevier in Immunology Letters
- Vol. 117 (1) , 81-90
Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase
- 1 April 2008
- Published by Elsevier in Immunology Letters
- Vol. 117 (1) , 81-90
Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase
- Open Access
- 1 August 2007
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 117 (8) , 2279-2288
Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis
The inhibition of apoptosis of infected host cells is a well-known but poorly understood function of pathogenic mycobacteria. We show that inactivation of the secA2 gene in Mycobacterium tuberculosis, which encodes a component of a virulence-associated protein secretion system, enhanced the apoptosis of infected macrophages by diminishing secretion of mycobacterial superoxide dismutase. Deletion of secA2 markedly increased priming of antigen-specific CD8+ T cells in vivo, and vaccination of mice and guinea pigs with a secA2 mutant significantly increased resistance to M. tuberculosis challenge compared with standard M. bovis bacille Calmette-Guérin vaccination. Our results define a mechanism for a key immune evasion strategy of M. tuberculosis and provide what we believe to be a novel approach for improving mycobacterial vaccines.
- 1 August 2007
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 117 (8) , 2279-2288
Open AccessEnhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis
The inhibition of apoptosis of infected host cells is a well-known but poorly understood function of pathogenic mycobacteria. We show that inactivation of the secA2 gene in Mycobacterium tuberculosis, which encodes a component of a virulence-associated protein secretion system, enhanced the apoptosis of infected macrophages by diminishing secretion of mycobacterial superoxide dismutase. Deletion of secA2 markedly increased priming of antigen-specific CD8+ T cells in vivo, and vaccination of mice and guinea pigs with a secA2 mutant significantly increased resistance to M. tuberculosis challenge compared with standard M. bovis bacille Calmette-Guérin vaccination. Our results define a mechanism for a key immune evasion strategy of M. tuberculosis and provide what we believe to be a novel approach for improving mycobacterial vaccines.
- 5 May 2007
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 64 (14) , 1824-1840
Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity
It is now well demonstrated that the repertoire of T cells includes not only cells that recognize specific MHC-presented peptide antigens, but also cells that recognize specific self and foreign lipid antigens. This T cell recognition of lipid antigens is mediated by a family of conserved MHC class I-like cell surface glycoproteins known as CD1 molecules. These are specialized antigen-presenting molecules that directly bind a wide variety of lipids and present them for T cell recognition at the surface of antigen-presenting cells. Distinct populations of T cells exist that recognize CD1-presented lipids of microbial, environmental or self origin, and these T cells participate in immune responses associated with infectious, neoplastic, autoimmune and allergic diseases. Here we review the current knowledge of the biology of the CD1 system, including the structure, biosynthesis and trafficking of CD1 molecules, the structures of defined lipid antigens and the types of functional responses mediated by T cells specific for CD1-presented lipids.
- 5 May 2007
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 64 (14) , 1824-1840
Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity
It is now well demonstrated that the repertoire of T cells includes not only cells that recognize specific MHC-presented peptide antigens, but also cells that recognize specific self and foreign lipid antigens. This T cell recognition of lipid antigens is mediated by a family of conserved MHC class I-like cell surface glycoproteins known as CD1 molecules. These are specialized antigen-presenting molecules that directly bind a wide variety of lipids and present them for T cell recognition at the surface of antigen-presenting cells. Distinct populations of T cells exist that recognize CD1-presented lipids of microbial, environmental or self origin, and these T cells participate in immune responses associated with infectious, neoplastic, autoimmune and allergic diseases. Here we review the current knowledge of the biology of the CD1 system, including the structure, biosynthesis and trafficking of CD1 molecules, the structures of defined lipid antigens and the types of functional responses mediated by T cells specific for CD1-presented lipids.
- 1 May 2007
- Published by Elsevier in Journal of Immunological Methods
- Vol. 323 (1) , 11-23
Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand α-galactosylceramide bound to mouse CD1d
- 1 May 2007
- Published by Elsevier in Journal of Immunological Methods
- Vol. 323 (1) , 11-23
Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand α-galactosylceramide bound to mouse CD1d
- 28 February 2006
- Published by Elsevier in Current Opinion in Immunology
- Vol. 18 (1) , 61-63
Antigen processing and recognition
- 28 February 2006
- Published by Elsevier in Current Opinion in Immunology
- Vol. 18 (1) , 61-63
Antigen processing and recognition